Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid
Study Details
Study Description
Brief Summary
This project will develop and test quality measures for and a facilitation model to help addictions treatment clinics increase use of medicines for opioid use disorders, retain clients longer in care, and help more people move into successful recovery. At the end of the project, we will have developed specific training and coaching protocols as well as electronic clinical support tools to guide quality improvement that can be disseminated within New York and the rest of the country.
The study will test a clinic-level intervention that uses external facilitators to provide guidance to addictions clinics and contain three key components: 1) training on data driven management; 2) training and guidance on patient-centered care and OUD medication; and 3) electronic tools for shared decision making and patient progress monitoring.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
There will be 4 sources of data examined in this study: 3 at the patient level and 1 at the staff level. The sources of patient data include: 1) State administrative data from all clients receiving treatment at the enrolled clinics (~7,950); 2) a subsample (1,200) who will be recruited directly from the clinics to complete patient-reported outcome assessments, and 3) treatment progress data for clients will also be collected.
For our administrative source of data, a final study population of approximately 7,950 individuals who are receiving treatment in the 30 enrolled outpatient treatment clinics for OUD is anticipated. Clinics will be located in the New York City metropolitan region (including Nassau, Westchester, and Rockland counties) and the Capital Region (including Albany, Rensselaer, Saratoga, Montgomery, Schenectady, and Schoharie counties). Staff at each enrolled clinic will also be interviewed and surveyed.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| No Intervention: Control
|
|
| Experimental: Metrics-driven quality improvement (MDQI) intervention
|
Behavioral: Metrics-driven quality improvement (MDQI)
The intervention broadly consists of training and coaching to clinic staff and leadership on 1) clinical quality measure monitoring; 2) clinical practice process change management; and 3) use of tools for shared decision making and patient treatment progress monitoring.
|
Outcome Measures
Primary Outcome Measures
- Change in clinic-level rates of initiation to OUD medications [Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.]
- Change in clinic-level rates of adherence to OUD medications [Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.]
- Retention in Care [Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.]
Clinic rates of 6-month client retention in care
- Change in Incidence of Overdoses [Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.]
- Change in Incidence of Substance Use-Related Hepatitis C Infection [Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.]
- Change in Number of Emergency Room Visits [Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.]
- Change in Health Status [Assessed from the start of each clinic in the intervention to 1 year post-intervention]
Change in health status is measured by the first item of the SF-12 Health Survey: "In general, would you say your health is: 1 - excellent, 2 - very good, 3 - good, 4 - fair, 5 - poor". Scores range from 1-5, with a higher score indicating worse health.
Secondary Outcome Measures
- Cost of treatment [Assessed from commencement of the intervention at each clinic to 1 year post-intervention]
Cost of the intervention to the clinic
- Change in clinic-level rates of clients with Severe OUD [Assessed from commencement of the intervention at each clinic to 1 year post-intervention]
As indicated by daily use and/or injection drug use as indicated in state administrative admission data
- Change in clinic level-rates of clients identified as homeless [Assessed from commencement of the intervention at each clinic to 1 year post-intervention]
As indicated in state administrative admission data
- Change in clinic-rates of clients with co-existing psychiatric disorder as indicated in state administrative admission data [Assessed from commencement of the intervention at each clinic to 1 year post-intervention]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Substance use disorder clinics in the regions surrounding New York City and the New York Capital Region with annual census of 50 or greater.
-
All staff and patients from participating clinics will be eligible to participate in the study.
-
Inclusion in the analyses using administrative data will be limited to those enrolled in Medicaid and not co-insured with Medicare (individuals ages greater than 64 and those with Federally determined disability).
Exclusion Criteria:
- Patients who are not working/being treated at substance use disorder clinics with less than 50 clients per year.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Samaritan Rockland - Outpatient Program | Blauvelt | New York | United States | 10913 |
| 2 | Samaritan Queens - Jamaica IOP | Jamaica | New York | United States | 11435 |
| 3 | Samaritan Daytop Village Harlem - Outpatient Program | New York | New York | United States | 10027 |
| 4 | Upper Manhattan Addiction Treatment Services Program | New York | New York | United States | 10031 |
Sponsors and Collaborators
- NYU Langone Health
- National Institute on Drug Abuse (NIDA)
- New York State Office of Addiction Services and Supports
- UConn Health
Investigators
- Principal Investigator: Charles Neighbors, PhD, NYU Langone Health
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 20-00776